All filters
Abstracts
Efficacy and Safety of Switching to B/F/TAF in Virologically Suppressed Asian Adults Living with HIV
A. Avihingsanon
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Pooled Analysis of the Efficacy, Safety, and Health Outcomes Following 48 Weeks of Long-acting Cabotegravir and Rilpivirine Maintenance Therapy for HIV-1 Infection in Phase 3 ATLAS and FLAIR Studies: Sub-Analysis in Asian Populations
J. Choi
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Efficacy and Safety of Switching to B/F/TAF in Virologically Suppressed Asian Women living with HIV
H. Wang
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Assessment of the safety of dolutegravir in HIV-infected patients from China: A real-world, open-label, multicenter, post-marketing surveillance study
F. Zhang
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Treatment Persistence among HIV-1 Patients Initiating Antiretroviral Therapy in Japan
T. Naito
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Safety and Efficacy of Genvoya® (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide, EVG/C/F/TAF) from the 3rd year Post Market Surveillance (PMS) Data in Korea
Y. Kim
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
The impact of gender on the clinical course of HIV infection in Yangon, Myanmar
P. Nyein
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Anti-Müllerian hormone levels and related factors of 715 HIV-infected women in childbearing age
D. Gong
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Analysis of total HIV-1DNA in peripheral blood after HAART in HIV-1/ HCV co-infected patients
C. Wen
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Switch-rate and switch-pattern of patients on 2-drug antiretroviral treatment – comparison to 3-drug regimen in a Japanese hospital claim database
D. Ruzicka
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
The Changes of Health-Related Quality-of-Life and Sleep Quality Following the Switch of Anti- Retroviral Treatment in Patients with Well-Controlled HIV Infection.
Y. Yoshino
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Factors associated with high alanine aminotransferase (ALT) and cirrhosis in people living with HIV on combination antiretroviral treatment (cART) in the Asia-Pacific
D. Rupasinghe
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Association of body mass index with immune recovery, virologic failure and cardiovascular disease risks among people living with HIV
W. Han
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Patient-Reported Outcomes and Body Weight Change among Patients Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide
L. Chen
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Effects of Syphilis Infection among HIV-1-Positive Individuals on Suppressive ART
P. Chan
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Cancer screening among people living with HIV
P. Wu
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Diabetes Mellitus is associated with incident liver cirrhosis in people living with HIV in Thailand: a prospective cohort analysis
T. Ueaphongsukkit
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease Among Aging Population
T. Ueaphongsukkit
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Fluconazole For Maintenance Therapy of Talaromyces marneffei Infection in Human Immunodeficiency Virus–Infected Patients
P. Ang
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Using of the Cobas Plasma Separation Card for HIV-1 RNA viral load at Pasteur Institute in Ho Chi Minh City, Vietnam
T. Vũ
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Virological and clinical outcomes of dolutegravir-based antiretroviral regimens in adolescents living with perinatally-acquired HIV infection with treatment failure on boosted protease inhibitors
N. Paiboon
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Analysis of clinical characteristics among the HIV-infected children with negative HIV antibody after antiviral treatment
L. Li
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Are MSM community ready for HIV self-testing reader? Results from a cross-sectional study
G. Marley
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Health facility staff feedback provides insights into stigma and discrimination and guides quality improvement in Cambodia
P. Sophat
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020